NovaBay Pharmaceuticals (NBY) 10-K2011 FY Annual report

Filed: 27 Mar 12, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: addressing, Adelaide, African, arbitration, article, back, Binomial, Black, block, blurred, Cataract, Chiltern, chosen, compelling, concerted, conference, consecutive, conserving, constructive, Continence, customer, David, Deferral, deposit, depressed, disability, Distinguishing, Eastern, edition, EKC, endpoint, Engineering, Eurozone, fifteen, Foundation, fundamental, gradually, Greek, highlighted, Hoon, impede, instrumental, invite, issuable, jeopardize, joined, Lattice, leadership, led, lieu, Macau, mainland, Middle, Mimicking, OAB, optimal, OUM, oversee, pace, Pioneer, placebo, post, poster, pre, preliminary, Professor, promising, properly, pure, put, Refractive, renegotiate, resolution, reverted, Rhinologic, Roy, Russell, SAWC, sheep, Simon, Stroman, subset, suited, Surgery, Symbio, Symposium, theme, titled, Today, Treasurer, uncovered, underway, unmet, unsatisfactory, USA, vacation, veterinary, Virbac, vision, won, Wormald, worth, Wu

Removed: accelerated, accuracy, allocated, analog, antimicrobial, bacterium, bloodstream, borrowing, catheterization, CAUTI, commitment, conform, consolidate, creating, creation, dated, dermal, destroy, dosing, duration, enhanced, expired, exploring, extremely, field, fungal, heightened, impaired, inflamed, institution, intensive, invading, invented, investor, KCI, Kinetic, marketplace, naturally, NCT, nose, notified, penalty, penetrate, penetration, platform, PM, reclassified, reliability, repaid, reversed, revision, routine, secured, stable, Toronto, TSX, Underwriter, unqualified

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

NBY similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of NovaBay Pharmaceuticals, Inc. (the Company) on Form 10-K for the fiscal year ended December 31, 2011 (the Report), I, Thomas J. Paulson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 26, 2012

/s/ Thomas J. Paulson

Thomas J. Paulson

Chief Financial Officer and Treasurer

This Certification is made solely for the purpose of 18 USC Section 1350, subject to the knowledge standard contained therein, and not for any other purpose.